Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas aeruginosa</i> Infection
Altered pharmacokinetics (PK) of hydrophilic antibiotics in critically ill patients is common, with possible consequences for efficacy and resistance. We aimed to describe ceftazidime population PK in critically ill patients with a proven or suspected <i>Pseudomonas aeruginosa</i> infect...
Main Authors: | Annabel Werumeus Buning, Caspar J. Hodiamont, Natalia M. Lechner, Margriet Schokkin, Paul W. G. Elbers, Nicole P. Juffermans, Ron A. A. Mathôt, Menno D. de Jong, Reinier M. van Hest |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/6/612 |
Similar Items
-
New Spectrophotometric Method for Estimation of Ceftazidime in pure and pharmaceutical dosage
by: Nibras Sabah Mohammed, et al.
Published: (2019-10-01) -
Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-05-01) -
Perbandingan Efektivitas Kombinasi Ceftazidime + Amikasin dan Ceftazidime sebagai Antibiotik Empiris Demam Neutropenia pada Keganasan
by: Agustinus William, et al.
Published: (2016-11-01) -
Ceftazidime as an empiric therapy for neonatal sepsis
by: Indrayady Indrayady, et al.
Published: (2021-08-01) -
In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)